Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma
Clinical trial NCT00942747 · UNKNOWN
Trial details
- NCT number
- NCT00942747
- Sponsor
- Charite University, Berlin, Germany
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-12-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.